Conroy O, Mazzella A, Choi H, Elmes J, Wilson M, Chudasama D
Microorganisms. 2025; 13(1.
PMID: 39858951
PMC: 11767419.
DOI: 10.3390/microorganisms13010183.
Wang J, Jiang T
BMC Infect Dis. 2025; 25(1):13.
PMID: 39754037
PMC: 11697680.
DOI: 10.1186/s12879-024-10420-1.
Srisurapanont K, Lerttiendamrong B, Meejun T, Thanakitcharu J, Manothummetha K, Thongkam A
Mycoses. 2024; 67(10):e13798.
PMID: 39379339
PMC: 11607781.
DOI: 10.1111/myc.13798.
Piccioni A, Franza L, Rosa F, Candelli M, Covino M, Ferrara M
Infect Med (Beijing). 2023; 2(3):202-211.
PMID: 38073889
PMC: 10699677.
DOI: 10.1016/j.imj.2023.04.006.
Satta G, Rawson T, Moore L
Infect Prev Pract. 2023; 5(4):100313.
PMID: 37920796
PMC: 10618700.
DOI: 10.1016/j.infpip.2023.100313.
Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves.
Pozza G, Casalini G, Ciubotariu C, Giacomelli A, Galimberti M, Zacheo M
Antibiotics (Basel). 2023; 12(9).
PMID: 37760744
PMC: 10525187.
DOI: 10.3390/antibiotics12091448.
Research on SARS-COV-2 pandemic: a narrative review focused on the Italian contribution.
De Cassai A, Longhini F, Romagnoli S, Cavaliere F, Caroleo A, Foti L
J Anesth Analg Crit Care. 2023; 1(1):14.
PMID: 37386621
PMC: 8596088.
DOI: 10.1186/s44158-021-00017-4.
Fungal-Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review.
Bantun F
J Fungi (Basel). 2023; 9(6).
PMID: 37367534
PMC: 10299597.
DOI: 10.3390/jof9060598.
Invasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study.
Bai X, Luo J
Int J Gen Med. 2023; 16:2419-2426.
PMID: 37333879
PMC: 10276605.
DOI: 10.2147/IJGM.S411006.
The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections.
Micheli G, Sangiorgi F, Catania F, Chiuchiarelli M, Frondizi F, Taddei E
Microorganisms. 2023; 11(5).
PMID: 37317274
PMC: 10222833.
DOI: 10.3390/microorganisms11051299.
Comparison of COVID-19 Severity and Mortality Rates in the First Four Epidemic Waves in Hungary in a Single-Center Study with Special Regard to Critically Ill Patients in an Intensive Care Unit.
Nagy E, Golopencza P, Barcs I, Ludwig E
Trop Med Infect Dis. 2023; 8(3).
PMID: 36977154
PMC: 10054791.
DOI: 10.3390/tropicalmed8030153.
Secondary infections in critically ill patients with viral pneumonia due to COVID-19 and influenza: a historical cohort study.
Beliavsky A, Johnston B, Li Q, Tomlinson G, Kaul R, Granton J
Can J Anaesth. 2023; 70(3):374-383.
PMID: 36918454
PMC: 10013978.
DOI: 10.1007/s12630-022-02376-0.
Yeast Bloodstream Infections in the COVID-19 Patient: A Multicenter Italian Study (FiCoV Study).
Prigitano A, Blasi E, Calabro M, Cavanna C, Cornetta M, Farina C
J Fungi (Basel). 2023; 9(2).
PMID: 36836391
PMC: 9962415.
DOI: 10.3390/jof9020277.
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.
Langford B, So M, Simeonova M, Leung V, Lo J, Kan T
Lancet Microbe. 2023; 4(3):e179-e191.
PMID: 36736332
PMC: 9889096.
DOI: 10.1016/S2666-5247(22)00355-X.
Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms.
Walsh T, Bright R, Ahuja A, McCarthy M, Marfuggi R, Simpson S
Open Forum Infect Dis. 2023; 10(1):ofac645.
PMID: 36686626
PMC: 9850274.
DOI: 10.1093/ofid/ofac645.
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.
Witt L, Howard-Anderson J, Jacob J, Gottlieb L
JAC Antimicrob Resist. 2023; 5(1):dlac130.
PMID: 36601548
PMC: 9798082.
DOI: 10.1093/jacamr/dlac130.
[Impact of the first year of the COVID-19 pandemic on the epidemiology of invasive infections (bacteremia) in the hospitals of the Assistance Publique-Hôpitaux de Paris].
Amarsy R, Robert J, Jarlier V
Bull Acad Natl Med. 2022; 207(2):131-135.
PMID: 36532694
PMC: 9745959.
DOI: 10.1016/j.banm.2022.11.013.
Incidence of bloodstream infections in patients with COVID-19: a retrospective cohort study of risk factors and outcomes.
Villatoro Santos C, Fukushima E, Zhao W, Sharma M, Youssef D, Spzunar S
Germs. 2022; 12(2):253-261.
PMID: 36504613
PMC: 9719389.
DOI: 10.18683/germs.2022.1327.
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Yazdanpanah S, Ahmadi M, Zare Z, Nikoupour H, Arabsheybani S, Jabrodini A
Mycopathologia. 2022; 188(1-2):9-20.
PMID: 36495418
PMC: 9739341.
DOI: 10.1007/s11046-022-00694-x.
Clinical outcomes of and risk factors for secondary infection in patients with severe COVID-19: a multicenter cohort study in South Korea.
Na Y, Baek A, Baek M, Kim W, Kim J, Lee B
Korean J Intern Med. 2022; 38(1):68-79.
PMID: 36420564
PMC: 9816674.
DOI: 10.3904/kjim.2022.084.
